Oracle and Rite Aid Set to Report Earnings, Cramer on Kinder
After opting to keep up the tobacco sales, unlike its big competitor in CVS, Rite Aid is looking to keep its streak of meeting and beating estimates alive.
The earnings parade rolls on with Rite Aid preparing to report results this morning before the bell -- after opting to keep up the tobacco sales, unlike its big competitor in CVS, Rite Aid is looking to keep its streak of meeting and beating estimates alive. After the bell, Oracle will report, as well, and there are more earnings on the way. Plus, Jim Cramer weighs in with his pick, Kinder Morgan Inc. Coming off of the company's mega-consolidation play, Cramer is bullish on the stock to jump from below the $40s all the way to $50 a share -- and he's looking for future M&A, as well.
